Empeal Health is a Digital Health startup founded in 2018 and based in Ireland. The company offers a Health Risk Management Tool that focuses on the prevention and management of chronic diseases. Empeal addresses the global burden of chronic diseases by shifting the focus from acute care to prevention and self-management.
When individuals with chronic diseases or those at high risk, such as diabetics or pre-diabetics, seek healthcare, they often receive recommendations regarding food, lifestyle, and medication. However, ensuring compliance with these recommendations is a challenge. Empeal's platform collects medical, nutrition, lifestyle, and behavior data, as well as personal goals from users through interactive questionnaires and integrated technologies like wearables. This data is leveraged to deliver highly personalized nutrition and lifestyle programs, enabling practitioners to visualize early trends and intervene effectively.
The latest investment in Empeal Health was a Non-Equity Assistance investment by Alsessor on 10th February 2021. The startup operates within the AI, Digital Health, Health Care, Health and Wellness, and SaaS industries.
No recent news or press coverage available for Empeal Health.